ShangPharma Corp Cash Per Share vs. Current Valuation
Considering ShangPharma Corp's profitability and operating efficiency indicators, ShangPharma Corp may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess ShangPharma Corp's ability to earn profits and add value for shareholders.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Please note, there is a significant difference between ShangPharma Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ShangPharma Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ShangPharma Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
For ShangPharma Corp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ShangPharma Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ShangPharma Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ShangPharma Corp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ShangPharma Corp over time as well as its relative position and ranking within its peers.
ShangPharma |
ShangPharma Corp Current Valuation vs. Cash Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining ShangPharma Corp's current stock value. Our valuation model uses many indicators to compare ShangPharma Corp value to that of its competitors to determine the firm's financial worth. ShangPharma Corp is currently regarded as top stock in cash per share category among its peers. It also is currently regarded number one company in current valuation category among its peers reporting about 46,657,187 of Current Valuation per Cash Per Share. Comparative valuation analysis is a catch-all technique that is used if you cannot value ShangPharma Corp by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.ShangPharma Current Valuation vs. Cash Per Share
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
ShangPharma Corp |
| = | 1.85 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
ShangPharma Corp |
| = | 86.32 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
ShangPharma Current Valuation vs Competition
ShangPharma Corp is currently regarded number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Pharmaceutical Products industry is at this time estimated at about 206.27 Billion. ShangPharma Corp adds roughly 86.32 Million in current valuation claiming only tiny portion of equities listed under Pharmaceutical Products industry.
ShangPharma Corp Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in ShangPharma Corp, profitability is also one of the essential criteria for including it into their portfolios because, without profit, ShangPharma Corp will eventually generate negative long term returns. The profitability progress is the general direction of ShangPharma Corp's change in net profit over the period of time. It can combine multiple indicators of ShangPharma Corp, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
ShangPharma Corporationration, through its subsidiaries, operates as a pharmaceutical and biotechnology research and development outsourcing company.
ShangPharma Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on ShangPharma Corp. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of ShangPharma Corp position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the ShangPharma Corp's important profitability drivers and their relationship over time.
Use ShangPharma Corp in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ShangPharma Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ShangPharma Corp will appreciate offsetting losses from the drop in the long position's value.ShangPharma Corp Pair Trading
ShangPharma Corp Pair Trading Analysis
The ability to find closely correlated positions to Sherwin Williams could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sherwin Williams when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sherwin Williams - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sherwin Williams Co to buy it.
The correlation of Sherwin Williams is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sherwin Williams moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sherwin Williams moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sherwin Williams can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your ShangPharma Corp position
In addition to having ShangPharma Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SRI Sustainable Growth Thematic Idea Now
SRI Sustainable Growth
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in ShangPharma Stock
If you are still planning to invest in ShangPharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ShangPharma Corp's history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |